Anne Vincent-Salomon Selected Research

Anne Vincent-Salomon Research Topics

Disease

113	Neoplasms (Cancer) 11/2022 - 03/2002
95	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2002
25	Neoplasm Metastasis (Metastasis) 04/2021 - 03/2002
19	Carcinoma (Carcinomatosis) 01/2022 - 11/2003
17	Triple Negative Breast Neoplasms 12/2021 - 01/2013
5	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 01/2004
5	Lymphatic Metastasis 01/2020 - 03/2002
3	Carcinogenesis 05/2021 - 12/2015
3	Ductal Carcinoma 11/2020 - 09/2010
3	Pathologic Complete Response 11/2019 - 06/2012
3	Residual Neoplasm 01/2018 - 01/2004
2	Lobular Carcinoma 01/2022 - 07/2013
2	Disease Progression 01/2021 - 01/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2007
2	Metaplasia 01/2017 - 03/2015
2	Papillary Carcinoma 12/2014 - 02/2012
2	Genomic Instability 01/2013 - 11/2009
2	Lymphoma (Lymphomas) 03/2012 - 09/2006
2	Infections 09/2010 - 09/2006
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2010 - 07/2006
2	Neoplasm Micrometastasis 03/2008 - 08/2005
1	Necrosis 01/2022
1	Fistula 01/2022

Drug/Important Bio-Agent (IBA)

24	Phenobarbital (Luminal)FDA Link 11/2022 - 12/2005
22	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
17	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2008
13	RNA (Ribonucleic Acid)IBA 10/2021 - 06/2007
13	Estrogen ReceptorsIBA 01/2021 - 02/2004
11	Trastuzumab (Herceptin)FDA Link 04/2022 - 12/2003
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2007
8	Hormones (Hormone)IBA 04/2021 - 11/2003
8	Biological ProductsIBA 01/2019 - 12/2005
6	Monoclonal AntibodiesIBA 12/2019 - 12/2003
5	Circulating Tumor DNAIBA 01/2022 - 01/2016
5	Indicators and Reagents (Reagents)IBA 05/2021 - 11/2003
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 02/2016
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 03/2005
4	Cadherins (E-Cadherin)IBA 01/2022 - 07/2013
4	palbociclibIBA 01/2022 - 01/2020
4	CollagenIBA 01/2022 - 10/2015
4	Metalloproteases (Metalloproteinases)IBA 01/2021 - 05/2014
4	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2021 - 05/2014
4	Keratins (Keratin)IBA 01/2014 - 06/2002
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 06/2010
3	AntibodiesIBA 12/2021 - 07/2013
3	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2009
3	ChromatinIBA 01/2019 - 04/2015
3	Oncogene Proteins (Oncogene Protein)IBA 10/2018 - 03/2007
3	AnthracyclinesIBA 01/2018 - 04/2002
3	Epithelial Cell Adhesion MoleculeIBA 01/2017 - 01/2004
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2014 - 01/2003
3	AntigensIBA 09/2010 - 01/2003
3	Rituximab (Mabthera)FDA Link 06/2009 - 07/2006
3	human ERBB2 proteinIBA 01/2008 - 05/2004
2	Aromatase InhibitorsIBA 01/2022 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 12/2021 - 01/2016
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2020
2	CytokinesIBA 05/2021 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 07/2007
2	EnzymesIBA 11/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 02/2020 - 12/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 02/2009
2	Dihydrotachysterol (AT 10)IBA 01/2020 - 03/2007
2	CortactinIBA 12/2018 - 05/2014
2	Peptide Hydrolases (Proteases)FDA Link 12/2018 - 10/2015
2	Protein Isoforms (Isoforms)IBA 11/2018 - 06/2004
2	Androgen Receptors (Androgen Receptor)IBA 08/2018 - 01/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 03/2012
2	ParaffinIBA 01/2018 - 11/2007
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 09/2008
2	ClaudinsIBA 01/2017 - 03/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2016 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012 - 07/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2012 - 07/2004
2	ErbB Receptors (EGF Receptor)IBA 10/2010 - 11/2003
2	FicollIBA 02/2004 - 01/2004
1	Etoposide (VP 16)FDA LinkGeneric 04/2022
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2022
1	NucleotidesIBA 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	OligonucleotidesIBA 01/2022
1	Codon (Codons)IBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 05/2021
1	Progesterone FDA LinkGeneric 04/2021
1	Estrogens (Estrogen)FDA Link 04/2021
1	methylamphotericin B (AME)IBA 01/2021
1	MyogeninIBA 01/2021
1	dabrafenibIBA 01/2021
1	DesminIBA 01/2021

Therapy/Procedure

39	Therapeutics 01/2022 - 11/2003
24	Drug Therapy (Chemotherapy) 01/2022 - 03/2002
12	Neoadjuvant Therapy 12/2021 - 11/2008
8	Radiotherapy 01/2022 - 12/2005
4	Precision Medicine 11/2021 - 04/2016
4	Immunotherapy 02/2021 - 01/2003
4	Segmental Mastectomy (Lumpectomy) 11/2009 - 03/2002
2	Aftercare (After-Treatment) 11/2019 - 04/2002
2	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 03/2002
2	Mastectomy (Mammectomy) 12/2003 - 03/2002